In modern cancer therapy the clinical application of platinum-based drugs is more and more limited by the occurrence of intrinsic or acquired resistances. In this context the potential use of dinuclear platinum complexes in chemotherapy is increasingly relevant. The novel complexes Pd(Bzdpa)Cl 2 , Pd 2 (C 4 H 8 (dpa) 2 )Cl 4 , and Pt 2 (C 4 H 8 (dpa) 2 )Cl 4 allow a direct comparison of mono-and dinuclear palladium and platinum complexes respectively deriving from a 2,2Ј-dipyridylamine (Hdpa) ligand system. They were characterized by single crystal X-ray analysis as well as infrared spectroscopy and elemental analysis. The cisplatin analogous mononuclear palladium complex Pd(Bzdpa)Cl 2 (1) (Bzdpa: (2,2Јdipyridylbenzyl)amine) belongs to a range of 2,2Ј-dipyridylaminebased compounds which were extensively studied in our laborato-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.